| Quarter | Holdings | Value ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
|---|---|---|---|---|---|---|
| Q2 2019 | 6 | 18,752 | VEA, VT, SCHD, VIG | 13F-HR | 8/1/2019 | 000117266119001601 |
| Q1 2019 | 6 | 18,847 | VEA, VT, SCHD, VIG | 13F-HR | 5/13/2019 | 000117266119001176 |
| Q4 2018 | 4 | 16,601 | VEA, VT, ALLEGIANCE BANCSHARES INC, INNOVATE BIOPHARMACEUTICLS I | 13F-HR | 2/1/2019 | 000117266119000283 |
| Q3 2018 | 5 | 25,866 | VEA, VT, AMZN, VIG | 13F-HR | 10/23/2018 | 000117266118001881 |
| Q2 2018 | 3 | 25,476 | VEA, VT, VTI | 13F-HR | 7/25/2018 | 000117266118001417 |
| Q1 2018 | 3 | 26,136 | VEA, VT, VTI | 13F-HR | 4/30/2018 | 000117266118000981 |
| Q4 2017 | 4 | 23,567 | VEA, VT, VTI, SPY | 13F-HR | 2/2/2018 | 000117266118000240 |
| Q3 2017 | 5 | 23,230 | VEA, VT, VTI, TYG | 13F-HR | 11/13/2017 | 000117266117001930 |
| Q2 2017 | 5 | 22,285 | VEA, VT, VTI, TYG | 13F-HR | 7/27/2017 | 000117266117001408 |
| Q1 2017 | 6 | 22,930 | VEA, VT, TYG, AAPL | 13F-HR | 5/15/2017 | 000117266117001123 |
| Q4 2016 | 2 | 9,010 | VT, TYG | 13F-HR | 2/14/2017 | 000117266117000614 |
| Q3 2016 | 4 | 8,124 | VT, TYG, SPY, VTI | 13F-HR | 11/14/2016 | 000117266116004194 |
| Q2 2016 | 5 | 8,157 | VT, TYG, DXJS, DXJ | 13F-HR | 8/15/2016 | 000117266116003788 |
| Q1 2016 | 6 | 7,675 | VT, TYG, DXJS, DXJ | 13F-HR | 5/16/2016 | 000117266116003343 |
| Q4 2015 | 7 | 58,107 | KYN, TYG, VT, SPY | 13F-HR | 2/16/2016 | 000117266116002740 |
| Q3 2015 | 18 | 76,836 | KYN, TYG, VT, EPD | 13F-HR | 11/16/2015 | 000117266115001994 |
| Q2 2015 | 7 | 101,474 | KYN, TYG, VT, DXJ | 13F-HR | 8/14/2015 | 000117266115001544 |
| Q1 2015 | 5 | 115,468 | KYN, TYG, VT, DXJ | 13F-HR | 5/14/2015 | 000117266115001058 |
| Q4 2014 | 11 | 115,115 | KYN, TYG, ISEE, VT | 13F-HR | 2/13/2015 | 000117266115000386 |